BRPI0911266A2 - ensaio de fator de crescimento similar à insulina peguilado - Google Patents

ensaio de fator de crescimento similar à insulina peguilado

Info

Publication number
BRPI0911266A2
BRPI0911266A2 BRPI0911266A BRPI0911266A BRPI0911266A2 BR PI0911266 A2 BRPI0911266 A2 BR PI0911266A2 BR PI0911266 A BRPI0911266 A BR PI0911266A BR PI0911266 A BRPI0911266 A BR PI0911266A BR PI0911266 A2 BRPI0911266 A2 BR PI0911266A2
Authority
BR
Brazil
Prior art keywords
growth factor
pegylated insulin
insulin
factor assay
growth
Prior art date
Application number
BRPI0911266A
Other languages
English (en)
Inventor
Andreas Schaubmar
Julia Schleypen
Kurt Lang
Tilman Schlothauer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0911266A2 publication Critical patent/BRPI0911266A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0911266A 2008-04-03 2009-03-31 ensaio de fator de crescimento similar à insulina peguilado BRPI0911266A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08006768 2008-04-03
PCT/EP2009/002319 WO2009121551A1 (en) 2008-04-03 2009-03-31 Pegylated insulin-like-growth-factor assay

Publications (1)

Publication Number Publication Date
BRPI0911266A2 true BRPI0911266A2 (pt) 2015-09-29

Family

ID=39717834

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911266A BRPI0911266A2 (pt) 2008-04-03 2009-03-31 ensaio de fator de crescimento similar à insulina peguilado

Country Status (13)

Country Link
US (2) US20110045510A1 (pt)
EP (1) EP2274624B1 (pt)
JP (1) JP5031923B2 (pt)
KR (1) KR20100119899A (pt)
CN (1) CN101965516A (pt)
AT (1) ATE533060T1 (pt)
AU (1) AU2009231186A1 (pt)
BR (1) BRPI0911266A2 (pt)
CA (1) CA2720478A1 (pt)
ES (1) ES2375606T3 (pt)
IL (1) IL207437A0 (pt)
MX (1) MX2010010313A (pt)
WO (1) WO2009121551A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012255066B2 (en) * 2011-05-18 2016-06-02 Takeda Pharmaceutical Company Limited Modification-dependent activity assays
CN104718453B (zh) 2012-10-03 2017-03-08 Gyros专利公司 酸性条件下分析物测定用方法和试剂盒
CN104697829B (zh) * 2015-02-10 2018-05-04 深圳市新产业生物医学工程股份有限公司 用于igf-ⅰ化学发光免疫检测的酸性处理剂、样本预处理方法、试剂盒及检测方法
US20190018025A1 (en) * 2015-12-31 2019-01-17 Siemens Healthcare Diagnostics Inc. Non-recombinant human insulin-like growth factor binding protein concentrate

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904584A (en) * 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides
US6235488B1 (en) * 1988-09-29 2001-05-22 Agilent Technologies, Inc. Surface preparation for chemical-specific binding
US5158875A (en) * 1989-08-25 1992-10-27 Amgen Inc. Production of biologically active insulin-like growth factor i from high expression host cell systems
NZ236819A (en) * 1990-02-03 1993-07-27 Max Planck Gesellschaft Enzymatic cleavage of fusion proteins; fusion proteins; recombinant dna and pharmaceutical compositions
US5681814A (en) * 1990-06-07 1997-10-28 Genentech, Inc. Formulated IGF-I Composition
DK0597033T3 (da) * 1991-08-01 1997-06-02 Genentech Inc IGF-1 til forbedring af den neurale tilstand
US5861373A (en) * 1991-08-01 1999-01-19 Genentech, Inc IGF-1 to improve the neural condition
US5824784A (en) * 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
US5932462A (en) * 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
US5672662A (en) * 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
EP1017794A1 (en) * 1997-02-06 2000-07-12 Novo Nordisk A/S Polypeptide-polymer conjugates having added and/or removed attachment groups
US20030204864A1 (en) * 2001-02-28 2003-10-30 Henry Daniell Pharmaceutical proteins, human therapeutics, human serum albumin, insulin, native cholera toxic b submitted on transgenic plastids
US7067485B2 (en) * 1997-11-07 2006-06-27 Chiron Corporation IGF-I composition and its use
US6767892B1 (en) * 1997-11-07 2004-07-27 Chrion Corporation Compositions providing for increased IGF-I solubility
US6248546B1 (en) * 1998-03-09 2001-06-19 Diagnostic Systems Laboratories, Inc. Assay of IGFBP complex
IL143834A0 (en) * 1999-01-06 2002-04-21 Genentech Inc Insulin-like growth factor (igf) i mutant variants
EP1141014B1 (en) * 1999-01-06 2004-12-08 Genentech, Inc. Insulin-like growth factor (igf) i mutant variant
PT1165119E (pt) * 1999-04-08 2004-02-27 Genentech Inc Composicao baseada em polipeptidos com cargas opostas
US6596849B1 (en) * 1999-05-28 2003-07-22 Academia Sinica Monoclonal-antibody for analysis and clearance of polyethylene glycol and polyethylene glycol-modified molecules
US7431921B2 (en) * 2000-04-14 2008-10-07 Maxygen Aps Interferon beta-like molecules
US20040014652A1 (en) * 2000-06-01 2004-01-22 Andre Trouet Tumor activated prodrug compounds and methods of making and using the same
CA2716959A1 (en) * 2000-12-07 2002-06-13 Eli Lilly And Company Glp-1 fusion proteins
WO2002094853A2 (en) * 2001-05-21 2002-11-28 Nektar Therapeutics Al, Corporation Antibodies specific for poly(ethylene glycol)
KR101162908B1 (ko) * 2002-12-26 2012-07-06 마운틴 뷰 파마슈티컬즈, 인크. 수용체-결합 활성이 보존된, 사이토카인, 케모카인,성장인자, 폴리펩티드 호르몬 및 이들의 길항제의 중합체접합체
AU2009231394B2 (en) * 2008-04-03 2013-09-05 F. Hoffmann-La Roche Ag Use of PEGylated IGF-I variants for the treatment of neuromuscular disorders

Also Published As

Publication number Publication date
ATE533060T1 (de) 2011-11-15
EP2274624A1 (en) 2011-01-19
IL207437A0 (en) 2010-12-30
KR20100119899A (ko) 2010-11-11
CA2720478A1 (en) 2009-10-08
ES2375606T3 (es) 2012-03-02
CN101965516A (zh) 2011-02-02
WO2009121551A1 (en) 2009-10-08
US20110045510A1 (en) 2011-02-24
AU2009231186A1 (en) 2009-10-08
EP2274624B1 (en) 2011-11-09
JP2011516843A (ja) 2011-05-26
JP5031923B2 (ja) 2012-09-26
MX2010010313A (es) 2010-11-05
US20130089875A1 (en) 2013-04-11

Similar Documents

Publication Publication Date Title
CY1121208T1 (el) Σκευασματα αντισωματος ναταλιζουμαμπης
CU20120095A7 (es) Antagonistas de pcsk9
EP2535351A3 (en) Dual specificity antibody fusions
ES2500066T3 (es) Anticuerpos frente a ferroportina y métodos de uso
WO2011047087A3 (en) Protein detection via nanoreporters
CL2007003771A1 (es) Polinucleotido que codifica antigeno de n. meningitidis; vector y celula huesped que lo comprenden; polipeptido codificado; anticuerpo que se une al polipeptido; composicion que comprende el polinucleotido, vector, celula, polipeptido o anticuerpo an
TW200745161A (en) Stable antibody formulation
WO2010011944A3 (en) Protein screeing methods
WO2009061413A3 (en) Hybrid fusion reporter and uses thereof
UA94628C2 (ru) Гуманизированное моноклональное антитело, которое связывается с steap-1, и его применение
CO6470889A2 (es) Espectrómetro sin cubeta
BRPI0923199A2 (pt) métodos e composições para detecção de anticorpos com fixação de complemento.
DK2064348T3 (da) Profilering af receptorfamilie
CR20120127A (es) Anticuerpos monoclonales
MA30922B1 (fr) Anticorps d'agonistes de trkb et leurs utilisations
WO2006076687A3 (en) Elisa assays using prion-specific peptide reagents
WO2011100749A3 (en) Methods and materials for detecting viral or microbial infections
BRPI0607323A2 (pt) composições e uso de polipeptìdeos e kits para a detecção de anticorpo que se liga especificamente a um polipeptìdeo
WO2008157697A3 (en) Copolymer assay
WO2011053565A3 (en) Compositions and methods for detecting a tauopathy
IL202598A0 (en) High sensitivity immunoassays and kits for the determination of peptides and proteins of biological interest
WO2010048588A3 (en) Directed engagement of activating fc receptors
WO2011091308A3 (en) Pipette tips
BR112012019475A2 (pt) "uso de um anticorpo monoclonal anti-cd 44 anticorpo anti-cd44 humanizado e kit para a detecção da presença de hnscc em uma amostra
BRPI0911266A2 (pt) ensaio de fator de crescimento similar à insulina peguilado

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.